MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-12-2026
AVITA Medical DIO Ratio 2011-2026 | RCEL
Annual DIO Ratio AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 202 | 258 | 181 | 129 | 312 | 138 | 227 | 825 | 749 | 1.25 K | 287 | 426 | 411 | 274 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.25 K | 129 | 405 |
Quarterly DIO Ratio AVITA Medical
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 224 | 252 | - | 185 | 300 | 385 | - | 161 | 121 | 135 | - | 119 | 126 | 101 | - | 148 | 73.2 | 83.7 | 219 | 137 | 125 | 55.2 | - | 54.7 | 67 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 385 | 54.7 | 154 |
DIO Ratio of other stocks in the Medical devices industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Alphatec Holdings
ATEC
|
271 | $ 11.75 | -3.29 % | $ 1.76 B |  USA |
 |
BioSig Technologies
BSGM
|
7.1 K | - | 37.08 % | $ 85.7 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
75.1 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
290 | - | - | $ 3.31 B | USA |
 |
Delcath Systems
DCTH
|
266 | $ 8.98 | -1.32 % | $ 322 M | USA |
 |
Lianluo Smart Limited
LLIT
|
50 | - | 24.59 % | $ 44.8 M |  China |
 |
Aziyo Biologics
AZYO
|
146 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
108 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
133 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
240 | - | -5.86 % | $ 30.6 M | USA |
 |
Second Sight Medical Products
EYES
|
175 | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
13.9 | $ 18.41 | 0.38 % | $ 121 M | USA |
 |
Conformis
CFMS
|
160 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
192 | - | 0.15 % | $ 844 M | USA |
 |
Inogen
INGN
|
47.7 | $ 6.32 | -2.02 % | $ 168 M | USA |
 |
Apollo Endosurgery
APEN
|
160 | - | - | $ 475 M | USA |
 |
IRIDEX Corporation
IRIX
|
125 | $ 1.35 | - | $ 21.8 M | USA |
 |
IRadimed Corporation
IRMD
|
206 | $ 100.97 | 1.78 % | $ 1.28 B | USA |
 |
Avinger
AVGR
|
332 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
312 | - | -4.14 % | $ 702 M | USA |
 |
LivaNova PLC
LIVN
|
127 | $ 62.4 | -1.33 % | $ 3.4 B |  Britain |
 |
LENSAR
LNSR
|
179 | $ 5.56 | -8.4 % | $ 64 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
247 | - | 1.15 % | $ 34.5 M | USA |
 |
AxoGen
AXGN
|
238 | $ 32.61 | 2.71 % | $ 1.5 B | USA |
 |
CONMED Corporation
CNMD
|
205 | $ 36.56 | -0.19 % | $ 1.13 B | USA |
 |
Medtronic PLC
MDT
|
168 | $ 86.58 | -0.68 % | $ 111 B | USA |
 |
Itamar Medical Ltd.
ITMR
|
212 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
856 | - | - | $ 1.08 M | USA |
 |
Electromed
ELMD
|
91.2 | $ 24.7 | 0.86 % | $ 209 M | USA |
 |
Misonix, Inc.
MSON
|
272 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
10.1 | - | - | $ 111 M |  Canada |
 |
InspireMD
NSPR
|
172 | $ 1.79 | 3.47 % | $ 115 M | Israel |
 |
Orthofix Medical
OFIX
|
258 | $ 11.72 | -1.26 % | $ 464 M |  Curacao |
 |
Intersect ENT, Inc.
XENT
|
145 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
106 | $ 0.7 | 3.3 % | $ 38.1 M | USA |
 |
BIOLASE
BIOL
|
154 | - | -13.19 % | $ 166 K | USA |
 |
Penumbra
PEN
|
332 | $ 334.17 | -0.41 % | $ 13 B | USA |
 |
AdaptHealth Corp.
AHCO
|
20.2 | $ 11.48 | 10.7 % | $ 1.55 B | USA |
 |
Myomo
MYO
|
81.8 | $ 0.7 | -1.83 % | $ 29.3 M | USA |
 |
Insulet Corporation
PODD
|
210 | $ 225.5 | -0.7 % | $ 15.9 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
32.1 | $ 2.4 | -1.64 % | $ 141 M | Israel |
 |
Invacare Corporation
IVC
|
82.8 | - | - | $ 24.7 M | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 3.91 | 4.83 % | $ 146 M |  France |
 |
Quanterix Corporation
QTRX
|
216 | $ 3.82 | -3.05 % | $ 163 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
719 | $ 15.91 | -3.4 % | $ 373 M | USA |
 |
Outset Medical
OM
|
269 | $ 3.53 | -2.35 % | $ 53.7 K | USA |